TYK353: Difference between revisions
m 1 revision imported |
m Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK" |
||
| Line 31: | Line 31: | ||
<p style="text-align: center;">[[TYK352|<Prev Question]] --- [[TYK354|Next Question>]]</p> | <p style="text-align: center;">[[TYK352|<Prev Question]] --- [[TYK354|Next Question>]]</p> | ||
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | <p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | ||
[[Category:TYK]] | |||
Latest revision as of 02:23, 25 September 2026
When should a patient who is starting doxorubicin receive an echocardiogram?
a) Prior to starting therapy
b) After initiation of therapy
c) Following completion of therapy
d) If the patient develops symptoms
e) All of the above
Click for Answer
Answer
Answer e. As discussed above, serial echocardiography is important for patients receiving (or those with a history of receiving) anthracyclines, including doxorubicin. Importantly, systolic function may appear normal in some patients but myocardial depressant medications (including most anesthetics) may unmask significant dysfunction. Therefore a high index of suspicion for dysfunction is always warranted in these patients.
Notes
- This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.